Filtered By:
Source: Heart, Lung and Circulation
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 240 results found since Jan 2013.
Inflammation and Atrial Electrical Remodelling in Patients With Embolic Strokes of Undetermined Source
About one third of ischaemic strokes are classified as embolic strokes of undetermined source (ESUS). A silent atrial fibrillation (AF) may play a pathogenic role in these strokes and P wave dispersion (PWD), representing an electrocardiographic (ECG) predictor for paroxysmal AF, thereby a potential marker of covert cardioembolism, was found to be increased in cryptogenic stroke. Furthermore, current evidence links AF to inflammation: inflammatory markers, such as high-sensitive C-reactive protein (hsCRP), have been related to the development and persistence of AF, possibly by promoting atrial remodelling.
Source: Heart, Lung and Circulation - May 7, 2018 Category: Cardiology Authors: Maurizio Acampa, Pietro Enea Lazzerini, Francesca Guideri, Rossana Tassi, Andrea Lo Monaco, Giuseppe Martini Tags: Original Article Source Type: research
Comorbidities and Ventricular Dysfunction Drive Excess Mid-Term Morbidity in an Indigenous Australian Coronary Revascularisation Cohort
There is a paucity of data in regards to longer term morbidity outcomes in Indigenous Australian patients undergoing coronary artery bypass grafting (CABG). No comparative data on re-infarction, stroke or reintervention rates exist. Outcome data following percutaneous coronary intervention (PCI) is also extremely limited. Addressing this gap in knowledge forms the major aim of our study.
Source: Heart, Lung and Circulation - April 24, 2018 Category: Cardiology Authors: Paul D Wiemers, Lucy Marney, Nicole White, Georgina Bough, Alistair Hustig, Wei Tan, Ching-Siang Cheng, Dong Kang, Sumit Yadav, Robert Tam, John F Fraser Tags: Original Article Source Type: research
Distal arch aneurysm repair using left subclavian artery transposition with stented elephant trunk in the hybrid repair era
Hybrid aortic arch repair is an invasive approach to the surgical management of distal aortic arch aneurysm. The complications associated with hybrid aortic arch repair, such as stroke and endoleaks, are not uncommon and late reintervention is frequent. We retrospectively reviewed our experience of distal aortic arch aneurysm repair using the stented elephant trunk procedure with left subclavian artery (LSCA)-left common carotid artery (LCCA) transposition in the hybrid repair era.
Source: Heart, Lung and Circulation - March 27, 2018 Category: Cardiology Authors: Rui-Dong Qi, Jun-Ming Zhu, Yong-Min Liu, Lei Chen, Cheng-Nan Li, Xiao-Yan Xing, Nan Zhang, Li-Zhong Sun Tags: Original Article Source Type: research
Distal Arch Aneurysm Repair Using Left Subclavian Artery Transposition with Stented Elephant Trunk in the Hybrid Repair Era
Hybrid aortic arch repair is an invasive approach to the surgical management of distal aortic arch aneurysm. The complications associated with hybrid aortic arch repair, such as stroke and endoleaks, are not uncommon and late reintervention is frequent. We retrospectively reviewed our experience of distal aortic arch aneurysm repair using the stented elephant trunk procedure with left subclavian artery (LSCA)-left common carotid artery (LCCA) transposition in the hybrid repair era.
Source: Heart, Lung and Circulation - March 27, 2018 Category: Cardiology Authors: Rui-Dong Qi, Jun-Ming Zhu, Yong-Min Liu, Lei Chen, Cheng-Nan Li, Xiao-Yan Xing, Nan Zhang, Li-Zhong Sun Tags: Original Article Source Type: research
NOACs Now Mainstream for the Use of Anticoagulation in Non-Valvular Atrial Fibrillation in Australia
The management of stroke risk in patients with non-valvular atrial fibrillation has changed over the past few years. This change has occurred due to the introduction of novel oral anticoagulants (NOACs) such as apixaban, rivaroxaban and dabigatran for the management of non-valvular atrial fibrillation. These agents have shown comparable stroke risk reduction to warfarin in large international multicentre trials [1 –3]. This has changed the clinical practice of many treating physicians since their introduction from 2011 to 2013.
Source: Heart, Lung and Circulation - March 22, 2018 Category: Cardiology Authors: Derk Pol, Claire Curtis, Satish Ramukumar, Logan Bittinger Tags: Brief Communication Source Type: research
Homocysteine and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis
Although many studies have investigated the association of blood homocysteine with major cardiovascular diseases such as coronary heart disease and stroke, research on its association with atrial fibrillation (AF) is scarce.
Source: Heart, Lung and Circulation - March 22, 2018 Category: Cardiology Authors: Yasuhiko Kubota, Alvaro Alonso, Susan R. Heckbert, Faye L. Norby, Aaron R. Folsom Tags: Original Article Source Type: research
NOACs Now Mainstream for the Use of Anticoagulation in Non-Valvular Atrial Fibrillation in Australia.
The management of stroke risk in patients with non-valvular atrial fibrillation has changed over the past few years. This change has occurred due to the introduction of novel oral anticoagulants (NOACs) such as apixaban, rivaroxaban and dabigatran for the management of non-valvular atrial fibrillation. These agents have shown comparable stroke risk reduction to warfarin in large international multicentre trials [1 –3]. This has changed the clinical practice of many treating physicians since their introduction from 2011 to 2013.
Source: Heart, Lung and Circulation - March 22, 2018 Category: Cardiology Authors: Derk Pol, Claire Curtis, Satish Ramukumar, Logan Bittinger Tags: Brief Communication Source Type: research
Homocysteine and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis
Although many studies have investigated the association of blood homocysteine with major cardiovascular diseases such as coronary heart disease and stroke, research on its association with atrial fibrillation (AF) is scarce.
Source: Heart, Lung and Circulation - March 22, 2018 Category: Cardiology Authors: Yasuhiko Kubota, Alvaro Alonso, Susan R. Heckbert, Faye L. Norby, Aaron R. Folsom Tags: Original Article Source Type: research
The Translation of Knowledge into Practice in the Management of Atrial Fibrillation in Singapore
Atrial fibrillation (AF) is a clinically significant cardiac arrhythmia known to increase the risk of stroke by at least four times. Stroke-risk assessment and thromboprophylaxis are vital components in AF management. Guidelines are available to standardise AF management, but physicians ’ adherence to the recommended guidelines has been low.The aims were to:1. Examine and compare the level of knowledge and current practice in AF management between cardiologists and non-cardiologist physicians in Singapore;2.
Source: Heart, Lung and Circulation - March 12, 2018 Category: Cardiology Authors: Fong Yeong Brigitte Woo, Toon Wei Lim, Wai San Wilson Tam Tags: Original Article Source Type: research
Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Stroke: Meta-Analysis of Randomised Trials
Patent foramen ovale (PFO) is a common anatomic variant associated with cryptogenic stroke. Percutaneous PFO closure in these patients to prevent recurrent neurological events has been controversial for decades, and mixed results have been reported from past and recent observational and randomised studies. This meta-analysis of randomised trials aims to compare the efficacy and safety of PFO closure with medical therapy for cryptogenic stroke patients.
Source: Heart, Lung and Circulation - March 12, 2018 Category: Cardiology Authors: Tom Kai Ming Wang, Michael Tzu Min Wang, Peter Ruygrok Tags: Original Article Source Type: research
The Translation of Knowledge Into Practice in the Management of Atrial Fibrillation in Singapore
Atrial fibrillation (AF) is a clinically significant cardiac arrhythmia known to increase the risk of stroke by at least four times. Stroke-risk assessment and thromboprophylaxis are vital components in AF management. Guidelines are available to standardise AF management, but physicians ’ adherence to the recommended guidelines has been low.The aims were to:1. Examine and compare the level of knowledge and current practice in AF management between cardiologists and non-cardiologist physicians in Singapore;2.
Source: Heart, Lung and Circulation - March 12, 2018 Category: Cardiology Authors: Fong Yeong Brigitte Woo, Toon Wei Lim, Wai San Wilson Tam Tags: Original Article Source Type: research
Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Stroke: Meta-Analysis of Randomised Trials
Patent foramen ovale (PFO) is a common anatomic variant associated with cryptogenic stroke. Percutaneous PFO closure in these patients to prevent recurrent neurological events has been controversial for decades, and mixed results have been reported from past and recent observational and randomised studies. This meta-analysis of randomised trials aims to compare the efficacy and safety of PFO closure with medical therapy for cryptogenic stroke patients.
Source: Heart, Lung and Circulation - March 12, 2018 Category: Cardiology Authors: Tom Kai Ming Wang, Michael Tzu Min Wang, Peter Ruygrok Tags: Original Article Source Type: research
Left Atrial Appendage Exclusion Using the AtriClip Device: A Case Series
Atrial fibrillation (AF) affects 1.5 –2% of the population and is associated with a five-fold increased lifetime risk of stroke [1]. The left atrial appendage (LAA) is the source of embolic strokes in up to 90% of patients with non-valvular AF with clots in the left atrium [2].
Source: Heart, Lung and Circulation - December 22, 2017 Category: Cardiology Authors: Sarah Page, Jane Hallam, Neelprada Pradhan, Brian Cowie, Tuong Phan, Desmond McGlade, Alex Rosalion, Andrew Newcomb, Michael Yii Tags: Original Article Source Type: research
